MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-06-15
DOI
10.1111/hepr.13685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study
- (2021) Madunil Anuk Niriella et al. PLoS One
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Diffuse optical assessment of cerebral‐autoregulation in older adults stratified by cerebrovascular risk
- (2020) Ahmed A. Bahrani et al. Journal of Biophotonics
- The Association of the Steatosis Severity in Fatty Liver Disease with Coronary Plaque Pattern in General Population
- (2020) Pai‐Feng Hsu et al. LIVER INTERNATIONAL
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- Letter regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”
- (2020) Lung-Yi Mak et al. JOURNAL OF HEPATOLOGY
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Response to: Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Vy H. Nguyen et al. LIVER INTERNATIONAL
- The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk
- (2020) Mayu Higashioka et al. Journal of Atherosclerosis and Thrombosis
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population
- (2019) Hiroyuki Hirai et al. Scientific Reports
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Profiles of advanced hepatic fibrosis evaluated by FIB‐4 index and shear wave elastography in health checkup examinees
- (2019) Sakura Yamamura et al. HEPATOLOGY RESEARCH
- Association between high-density lipoprotein cholesterol and all-cause mortality in the general population of northern China
- (2019) Xintao Li et al. Scientific Reports
- Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
- (2019) Shiv K Sarin et al. Lancet Gastroenterology & Hepatology
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Biostatistics series module 3: Comparing groups: Numerical variables
- (2016) Avijit Hazra et al. INDIAN JOURNAL OF DERMATOLOGY
- Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2015) Sumio Watanabe et al. HEPATOLOGY RESEARCH
- Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study
- (2014) Kunihiro Nishimura et al. Journal of Atherosclerosis and Thrombosis
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now